Despite Affordability, Low Utilization of Lipid Lowering Drugs in Iran: Trend Analysis and Benchmarking 2005-2016

Dyslipidemia is responsible for great mortality and morbidity each year. Little data are available on the availability and affordability of Dyslipidemia medications in low and middle incomes countries. In a retrospective time-series study, we examined the utilization pattern and affordability of lip...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Iran J Pharm Res
Egile Nagusiak: Zartab, Saman, Abbassian, Hadi, Nassiri Koopaei, Nasrin, Hajimolaali, Mohammad
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Shaheed Beheshti University of Medical Sciences 2019
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6706728/
https://ncbi.nlm.nih.gov/pubmed/31531093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22037/ijpr.2019.1100695
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak